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Nephrotic syndrome (NS) is a consequence of the 
reduced ability of the glomerulus barrier to exclude
proteins of intermediate size (40–200 kDa) and other
macromolecules from urine. Substances lost in urine
include albumin, immunoglobulins, hormones, and
proteins that modulate the coagulation cascade [1,2].
The well-known clinical features of NS include
hypoalbuminemia, abnormal lipid profiles, edema,
and hypercoagulability. These systemic complications
of NS are responsible for much of the morbidity and
mortality seen with this condition. Thromboembolism
is one of the most serious, but frequently overlooked,
extrarenal complications [3]. The exact incidence of
thromboembolism in NS is not known, but varies
from 6% to 44% in the literature [4,5]. One of the rea-
sons for the increased coagulation is the loss of small
proteins (antithrombin-III, proteins C, and protein S)
and the increased concentrations of procoagulants
because of their high molecular weight [6]. Although
the majority of embolic episodes in nephrotic pa-
tients involve the venous system, significant arterial
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We report a 23-year-old male presenting with edema. He was originally admitted for an elective
renal biopsy for diagnosis of renal pathology. Unfortunately, because of acute abdominal pain an
exploratory laparotomy was done. Progressive azotemia and oliguria then developed, and he
required temporary hemodialysis. However, he suffered from sudden-onset severe respiratory
distress, and blood gas analysis showed profound hypoxemia with a marked arterial–alveolar
oxygen difference. Assessment of a pulmonary embolism by radioisotope imaging was not possi-
ble because of his dependence on mechanical ventilation. Subcutaneous low molecular weight
heparin and intravenous methylprednisolone were given to treat the presumed pulmonary
embolism and the underlying nephrotic syndrome. His partial oxygen level gradually increased
after continuous heparin and steroid administration. Complete obliteration of one major pul-
monary artery and partial obliteration of other smaller arteries were revealed by magnetic reso-
nance angiography. He was discharged and followed-up as an outpatient, and was given oral
warfarin and prednisolone. Follow-up magnetic resonance angiography 5 months later showed 
a normal pulmonary tree with no residual lesions.
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thromboses can occasionally occur [7]. Pulmonary
embolism (PE) is a rare, but clinically significant situ-
ation and more sensitive methods have revealed evi-
dence of PE in more than 15% of NS patients [4,7].
Here, we report a patient with NS who developed
severe PE and consequently life-threatening respira-
tory distress. Treatment with steroids and heparin
was successful, and the embolic lesions were clearly
demonstrated by magnetic resonance angiography
(MRA).
CASE PRESENTATION
A 23-year-old male was admitted to our hospital with
decreased urine volume, lower-limb edema and body
weight gain during the preceding week. He was a
healthy college student, and did not have any history
of systemic illness. Two weeks before admission, he re-
ported pain in the epigastric area. A gastroendoscopic
examination was performed, but only mild gastric
mucosal erosion was found. Routine urinalysis showed
microscopic hematuria with 5–10 red blood cells per
high power field and presence of proteinuria (+++)
semi-quantitatively using dipsticks (Hema-Combistix,
Bayer Diagnostics). Under the impression of nephrotic
syndrome, he was admitted for further evaluation and
elective renal biopsy.
Physical examination revealed a body weight of
70 kg, a regular pulse of 80 beats/min, and high blood
pressure of 140/94mmHg at that time. His conjunctiva
was not pale or injected. There was no jugular venous
engorgement, and his heart sound was normal. His
breathing sounds, rate and pattern were also normal.
He felt no tenderness upon palpation on the abdomen
and his bowel sound was not hyperactive. However,
moderate degree of bilateral lower limb edema was
noted. Laboratory examinations showed a normal
hemogram (white blood cells, 6.28 × 103/μL; hemo-
globin, 14.7 g/dL; and platelets, 322 × 103/μL). Bio-
chemical analysis showed albumin, 2.03 g/dL;
cholesterol, 365.4 mg/dL; triglycerides, 951.3 mg/dL;
blood urea nitrogen, 34.5 mg/dL; creatinine, 1.6 mg/
dL; and uric acid, 9 mg/dL. The prothrombin time
and activated partial thromboplastin time were within
normal ranges. Plasma electrolyte levels were also nor-
mal, but urinary sodium was only 7 mmol/L (normal
range, 15–250 mmol/L). Routine urinalysis showed
severe proteinuria and microscopic hematuria with
dysmorphic changes. His creatinine clearance was only
9.8 mL/min and he lost 10.1 g of creatinine into urine
per day. The antinuclear antibody test was negative
and the immunoglobulin (Ig) G, IgA, and IgM levels
were 107.0, 136.0, and 87.3 mg/dL, respectively. Ultra-
sonography revealed enlarged bilateral kidneys with
increased echogenicity.
Sudden onset of abdominal pain over the right
lower abdominal area with a positive peritoneal res-
ponse and fever (38.8°C) developed 4 hours after
admission. Exploratory laparotomy was done on the
same day under the impression of peritonitis. During
the operation, more than 1.5 L of chyle-like ascites was
obtained (cell count, 52 × 119/L; polymorphic neu-
trophils/monocytes, 5/47; lactate dehydrogenase,
219 U/L; total protein, 0.034 g/L; triglyceride,
830.8 mg/dL) and bacterial peritonitis with Escherichia
coli was diagnosed.
His postoperative recovery was satisfactory. How-
ever, progressive azotemia, oliguria, and marked
pulmonary congestion were then developed, despite
the use of diuretics. Thus, temporary hemodialysis
was carried out to correct the elevated serum blood
urea nitrogen and creatinine levels of 114.9 mg/dL
and 9.1 mg/dL, respectively. Shortly after two sessions
of hemodialysis, severe dyspnea developed. A chest
X-ray revealed bilateral pleural effusions. Cardio-
pulmonary resuscitation rapidly restored his cardiac
rhythm, and he was placed on assisted mechanical
ventilation supported with 100% oxygen (O2). After
resuscitation, his arterial blood gas analysis showed
pH, 7.325; partial pressure (Pa) of carbon dioxide,
28.2 mmHg; PaO2, 42.9 mmHg; HCO3–, 14.3 mM; and
O2 saturation, 76%. PE was highly suspected because
of the marked arterial–alveolar difference in O2 con-
tent (634.8 mmHg; normal < 15 mmHg).
Another complication, upper gastrointestinal hem-
orrhage, as demonstrated by the outflow of finely
ground substances from the nasogastric tube, also
prevented the use of heparin for PE. His serum fib-
rinogen was found to be at a very high level (13.1 g/L;
normal, 1.51–3.75g/L) and D-dimer was not detectable.
The hemorrhage was not aggravated after observa-
tion for 12 hours. Heparinization, using low molecular
weight heparin (4,100 U/0.4 mL, Fraxiparin®; Sanofi
Winthrop, New York, NY, USA), was given subcuta-
neously three times per day. He was also treated with
500mg methylprednisolone twice daily for 3 days fol-
lowed by 1 mg/kg/day of oral prednisolone. His renal
function deteriorated because of the unstable cardio-
pulmonary condition, and we had to treat his renal
failure with continuous arterio-venous hemodialysis.
Unfortunately, tension pneumothorax developed and
caused a cardiac arrest event. The immediate insertion
of a 28-French chest tube rapidly relieved the severe
situation.
After the use of low molecular weight heparin for
7 days, extubation of the endotracheal tube and wean-
ing from the ventilator became feasible because the
follow-up blood gas analysis showed a gradual im-
provement in PaO2, and the O2 concentration used in
the ventilator could be tapered. A 99mTc-diethylene-
triaminopentaacetic acid lung ventilation and 99mTc-
macroaggregated albumin perfusion (99mTc-MAA/
DTPA) scans were performed immediately after extu-
bation and revealed significant segmental perfusion
defects in the posterior basal segment of the right lung
(Figure 1). MRA was performed to reveal the local-
ization of the vascular lesions. It revealed a space-
occupying lesion in the right superior pulmonary
artery (a remnant embolus) and decreased vascular-
ity over the right lower lung (Figure 2A). His respira-
tory condition remained stable and the renal biopsy
was obtained smoothly. He was discharged and fol-
lowed up as an outpatient, and treated with 1 mg/
kg/day prednisolone and 2.5mg/day warfarin. Histo-
logical analysis of his kidney tissue showed a grossly
normal glomerulus. There was no electro-dense dep-
osition and electronic microscope examination showed
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Figure 1. 99mTc MAA/DTPA aerosol lung perfusion/ventilation scan performed after extubation of the endotracheal tube and with the
patient breathing unassisted. The scan showed significant segmental perfusion defects (arrows) in the posterior basal segment of (A)
right lung in the posterior and (B) in the right posterior oblique view.
BA
Figure 2. Pulmonary arterial embolism shown by the magnetic resonance angiography performed after the respiratory distress was
resolved. (A) Filling defect (remnant thrombus) in the right superior pulmonary artery (arrow) and abrupt interruption of right inferior
pulmonary artery with decreased vascularity over the right lower lung, versus the vascularity over the left side. (B) Magnetic resonance
angiography was repeated 5 months later, and no filling defect was found.
effaced foot processes. The above findings were com-
patible with the diagnosis of minimal change disease.
MRA was performed 5 months later and showed
no filling defect in the previously obliterated vessels
(Figure 2B). Urine protein became negative after
steroid treatment for 6 weeks and serum albumin
increased to 4.4 mg/dL. The steroid dose was gradu-
ally tapered and he is now receiving 5mg prednisolone
every 2 days, and his serum creatinine level has
improved to 1.2 mg/dL.
DISCUSSION
Hypercoagulability and thromboembolism are well-
known features of NS and thromboembolic compli-
cations have emerged as a major complication of NS
[8]. As early as 1948, Addis et al drew attention to the
high incidence of these complications in NS patients
[9]. More recent studies have shown that thromboem-
bolic complications occur in approximately 40% of
adults with NS and in 1.8–5.0% of children [10]. Throm-
boembolic complications are more frequent when the
NS is due to membranous glomerulonephritis [11].
Although thromboembolic complications develop in
both the venous and arterial sides of the systemic cir-
culation, arterial thrombosis is less common than
venous thrombosis in adults with NS [12,13]. PE is one
of the most serious complications, causing severe mor-
bidity, and is mainly reported in children with NS,
rarely in adults [14–16]. The incidence of PE is not 
exactly known, but lung scintigraphy revealed that 
it was possibly present in one-third of adults with
clinically silent NS [17]. However, it is usually life-
threatening once it is clinically manifested. Our pa-
tient with minimal change disease experienced an
unusually dangerous course of NS, chiefly intervened
by the development of clinically manifested PE. The
possibility of genetic defects might be due to the fact
that the development of PE is rarely associated with
nephritic syndrome in minimal change disease.
The hypercoagulable state has been related to 
abnormalities in coagulation factors. Small proteins
(antithrombin-III, protein C, and protein S) that
inhibit clotting are lost into the urine because of their
small size [18,19]. Increased coagulation factors (V,
VIII and fibrinogen) also contribute to clot formation
[20]. Other factors that may enhance the hypercoagu-
lable state in NS include increased fibrinogen level,
intensive diuretic and steroid treatment, and reduced
vascular volume [21,22]. Our patient had a very low
serum albumin level (2.03 g/dL) and the resulting
vascular contraction (revealed by very low urinary
sodium levels) was so severe that it caused acute
renal failure. More than 10 g of protein was lost into
urine and large amounts of antithrombin-III (and
protein C and protein S) may also have been lost, al-
though the amounts were not examined. His fibrino-
gen level was very high. He underwent abdominal
surgery and his hydration status might have been
aggravated by inadequate postoperative fluid supply.
These factors—hypoalbuminemia, hyperfibrinogen-
emia, contracted volume status, abnormal coagula-
tion factors, inadequate fluid supply and the need for
dialysis (and the inevitable decline in vascular vol-
ume during the procedures)—all contributed to the
development of severe PE and the life-threatening
clinical course for this patient.
Little published data are available on the inci-
dence of PE in adult patients with NS and, hence, the
exact incidence is unknown. Mehls et al retrospec-
tively reviewed and analyzed the clinical course of
116 adult patients (average age of 34 years) with NS.
They found that 8.6% (10/116 patients) of NS cases
were noted as having PE during admission [23].
However, the methods used for the diagnosis of PE
were not described, and this might mean the incidence
(8.6%) is not substantial. By using ventilation/perfu-
sion (V/Q) lung scintigraphy (133Xe for ventilation
and 99mTc MAA for perfusion imaging), Cherng et al
studied the incidence of PE in 89 adult patients with
NS with severe hypoalbuminemia (< 2.0 g/dL) [17].
They reported that 21% of the patients had a high
probability of PE, 49% had intermediate probability,
21% had low probability, and 9% had no or very low
probability. They had also performed pulmonary
angiography correlation analysis, but only on 40% 
of the patients with intermediate or low probabilities,
and they found evidence of PE in 10 of those patients.
Moreover, angiography was not done for cases with
high or very low probabilities. Consequently, the false-
positive and false-negative prediction rates of the
lung scans are unknown. Therefore, the exact role of
lung scans on the identification of PE remains unclear.
Our patient represented a severe situation because he
experienced not only marked dyspnea, but also pro-
found hypoxemia, and this directly prompted the
suspicion of PE, which was later confirmed by a lung
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scan and MRA. Conventional angiography has a lead-
ing role in the diagnosis of vascular defects, but this
may be challenged by more recent techniques such as
MRA, particularly when the patient’s condition means
that conventional angiography cannot be performed.
The role of MRA in the diagnosis of PE has been re-
ported and shows high sensitivity and specificity
[24,25]. In our opinion, MRA is a reliable alternative
to conventional angiography for the diagnosis of PE
because of its noninvasiveness, its wide applicability
to most patients, the lower exposure to X-rays, and
the reduced burden of iodinated contrast medium.
PE is a potentially fatal disorder, particularly when it
occurs with certain illnesses. The mortality rate is rel-
atively low (2.5%) if appropriate treatment is applied
[26]. Anticoagulant therapy with heparin is essential
once thromboembolic events have been documented.
However, successful treatment with urokinase, anti-
thrombin III concentrate, and tissue plasminogen
activator were also reported [27,28]. The potential
benefit of prophylactic anticoagulation for patients
with membranous nephropathy has been examined
with decision analysis, and it was shown to be safer
than ad hoc anticoagulation [29]. Nevertheless, pro-
phylactic anticoagulation should be considered only
if the risk is high, such as in the presence of severe
hypoalbuminemia (<2.0g/dL) or marked volume con-
traction, after considering the inevitable risk of bleed-
ing. We treated this patient with subcutaneous low
molecular weight heparin instead of conventional
non-fractioned heparin, because he experienced upper
gastrointestinal tract hemorrhage. This treatment was
successful and satisfactory. Low molecular weight
heparin was reported as a preventative measure for
thrombotic complications in NS; one case report has
described the use of subcutaneous low molecular
weight heparin for the treatment of PE in patients with
NS [30,31]. Further studies are needed to document
its effectiveness.
In conclusion, PE is a relatively rare complication
in adult patients with NS. Once it is clinically mani-
fested, it usually contributes to morbidity and, occa-
sionally, mortality. Immediate identification and
prompt anticoagulation are necessary for rescue. Lung
scintigraphy followed by angiography is the most
commonly used diagnostic method, but MRA may 
be an effective alternative in some situations when
the patient’s condition is not suitable for conven-
tional angiography. For anticoagulation therapy, 
low molecular weight heparin can be an alternative
to non-fractionated heparin, although the effective-
ness of this approach needs further confirmation.
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腎病症候群合併致命性肺動脈栓塞 — 
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本文報告一例 23 歲男性，因為下肢水腫而住院實施腎臟切片。住院後因為急性腹痛
而實施剖腹手術。而後因為寡尿及氮血症而短暫的施行血液透析。不幸的突然發生嚴
重的呼吸衰竭，動脈氣體分析顯示低血氧及明顯的動脈 –肺泡氧氣飽和度差，懷疑是
發生肺動脈栓塞，但因為插了氣管內管而無法實施核子醫學造影。為治療肺動脈栓塞
及本身腎病症候群，給予皮下低分子量肝素及靜脈注射類固醇。在經過肝素及類固醇
治療後，病人血中氧濃度逐漸上升，成功拔管。核磁共振血管攝影顯示一條主肺動脈
完全阻塞及其他小動脈部份阻塞。病人出院後於門診規則服用口服可邁丁錠
（warfarin）及類固醇。五個月後追蹤其核磁共振血管攝影：呈現正常肺動脈血管攝
影，無阻塞情形。
關鍵詞：低分子量肝素，腎病症候群，肺動脈栓塞
（高雄醫誌 2010;26:89–95）
